Nuformix plc Innovative Drug Repurposing with Breakthroughs in Fibrosis and Oncology
Nuformix plc Innovative Drug Repurposing with Breakthroughs in Fibrosis and Oncology
United States Japanese National Phase Patent Application No Business Development Idiopathic Pulmonary Fibrosis Orphan Drug Designation Target Product Profile
Source: directorstalkinterviews.com